Cargene Therapeutics
PrivateLast Round
Early Funding
Dec 14, 2021
Total Funding Raised
$19.2M
Company Overview
Cargene Therapeutics operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was an Early Funding round in December 2021.
Cargene Therapeutics is a biotechnology company that develops innovative oligonucleotide therapeutics for liver, cardiometabolic, and ophthalmic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cargene Therapeutics Comparables
Compare Cargene Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanegene Bio | 85% | |
| Rona Therapeutics | 83% | |
| Switch Therapeutics | 81% |
For institutional investors. Book with your work email.
Cargene Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Cargene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Early Funding |
| Hyfinity Investments | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2024
Monthly visitors increased 287% MoM, from 310 to 1.2K.
- Oct 29, 2024
Monthly visitors grew 123% MoM, from 139 to 310.
For institutional investors. Book with your work email.
Cargene Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cargene Therapeutics's valuation, stock price, and market status.
Is Cargene Therapeutics a public or private company?
Cargene Therapeutics is a private company.
What is the current stock price of Cargene Therapeutics?
Cargene Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cargene Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cargene Therapeutics worth (valuation)?
Valuation information for Cargene Therapeutics is not publicly available.
Can I buy Cargene Therapeutics stock?
Cargene Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cargene Therapeutics's last funding round?
Cargene Therapeutics's most recent funding round was Early Funding on December 14, 2021.
Who are the main investors in Cargene Therapeutics?
Key investors in Cargene Therapeutics include BioTrack Capital.
Will Cargene Therapeutics IPO soon?
No public IPO plans have been announced for Cargene Therapeutics.
How can I track Cargene Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cargene Therapeutics's shares on secondary markets.